“…Symptoms typically associated with hyponatremia (including somnolence, headache, nausea, vomiting, convulsion, and partial seizures with secondary generalization) were reported more frequently in patients with the lowest minimum postdose [Na + ] levels (Group A) than in patients with no postdose [Na + ] measurements below 135 mEq/L (Group D) in the adjunctive trials. Similarly, dizziness, nausea, blurred vision, and diplopia were more frequent in patients with a moderate reduction in minimum postdose [Na + ] level (Group B) compared with Group D. In the monotherapy trials, dizziness, nausea, vomiting, fatigue, blurred vision, and nasopharyngitis were more frequent in Group A than in in Group D, and dizziness and nasopharyngitis were more frequent in patients in Group B vs Group D. Overall, somnolence, headache, nausea, and vomiting, all of which can be symptoms of acute hyponatremia, 26 were generally more frequent in patients with low [Na + ] in these trials of ESL, suggesting that [Na + ] ≤125 mEq/L, and even ≤130 mEq/L, may sometimes be symptomatic.…”